Granahan Investment Management, LLC Editas Medicine, Inc. Transaction History

Granahan Investment Management, LLC

$2.38 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$14.08 - $27.63 $1.76 Million - $3.46 Million	-125,183 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$26.55 - $40.57 $40,249 - $61,504	1,516 Added 1.23%	125,183 $3.32 Million
Q3 2021 Nov 15, 2021	SELL	$39.27 - $72.94 $573,302 - $1.06 Million	-14,599 Reduced 10.56%	123,667 $5.08 Million
Q2 2021 Aug 16, 2021	BUY	$31.29 - $56.64 $224,098 - $405,655	7,162 Added 5.46%	138,266 $7.83 Million
Q1 2021 May 17, 2021	SELL	$39.71 - $90.58 $956,931 - $2.18 Million	-24,098 Reduced 15.53%	131,104 $5.51 Million
Q4 2020 Feb 12, 2021	SELL	$27.07 - $84.35 $758,988 - $2.37 Million	-28,038 Reduced 15.3%	155,202 $10.9 Million
Q3 2020 Nov 12, 2020	BUY	$28.06 - $37.16 $3.17 Million - $4.2 Million	112,935 Added 160.64%	183,240 $5.14 Million
Q2 2020 Aug 14, 2020	BUY	$18.5 - $34.34 $291,708 - $541,473	15,768 Added 28.91%	70,305 $2.08 Million
Q1 2020 May 12, 2020	SELL	$14.88 - $32.78 $12,023 - $26,486	-808 Reduced 1.46%	54,537 $1.08 Million
Q4 2019 Feb 14, 2020	BUY	$19.49 - $32.63 $6,392 - $10,702	328 Added 0.6%	55,345 $1.64 Million
Q3 2019 Nov 15, 2019	BUY	$22.49 - $26.81 $94,930 - $113,165	4,221 Added 8.31%	55,017 $1.25 Million
Q2 2019 Aug 14, 2019	SELL	$20.48 - $27.76 $31,375 - $42,528	-1,532 Reduced 2.93%	50,796 $1.26 Million
Q1 2019 May 14, 2019	SELL	$19.43 - $26.41 $74,319 - $101,018	-3,825 Reduced 6.81%	52,328 $1.28 Million
Q4 2018 Feb 13, 2019	SELL	$18.19 - $31.79 $362,053 - $632,748	-19,904 Reduced 26.17%	56,153 $1.28 Million
Q3 2018 Nov 13, 2018	SELL	$27.65 - $38.39 $41,419 - $57,508	-1,498 Reduced 1.93%	76,057 $2.42 Million
Q2 2018 Aug 15, 2018	BUY	$31.4 - $41.01 $205,638 - $268,574	6,549 Added 9.22%	77,555 $2.78 Million
Q1 2018 May 14, 2018	SELL	$29.84 - $44.08 $1.05 Million - $1.55 Million	-35,195 Reduced 33.14%	71,006 $2.35 Million
Q4 2017 Feb 12, 2018	SELL	$21.89 - $31.34 $2.97 Million - $4.25 Million	-135,518 Reduced 56.06%	106,201 $3.26 Million
Q3 2017 Nov 14, 2017	BUY	$15.81 - $24.01 $3.82 Million - $5.8 Million	241,719	241,719 $5.8 Million

Others Institutions Holding EDIT

# of Institutions

248

Shares Held

57M

Call Options Held

410K

Put Options Held

394K

Black Rock Inc. New York, NY

7.78M
Shares

$20.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$17.8 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.9M
Shares

$13 Million
0.62% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.35M
Shares

$8.91 Million
0.01% of portfolio
State Street Corp Boston, MA

2.46M
Shares

$6.55 Million
0.0% of portfolio

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $183M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Granahan Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granahan Investment Management, LLC with notifications on news.

Account